Deal History
About us
The Company
Team
Offices
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Healthcare
Software & TMT
Energy & Infrastructure
Career
Events
Insights
News
Company News
Deal News
In the Media
Newsletter
Contact
Newsletter
US
INT
DA
DE
FR
SV
Main menu button
Team
Deals
Contact
Team
Deals
Contact
News
All
Company News
Deal News
Equity Research
Events
In the Media
Insights
Macro and Markets
25 Feb 2026
Equity research Immunovia Q4 2025: Targeting Medicare sub-mission by mid-2026
Equity Research
Immunovia
24 Feb 2026
Equity research Immunovia Q4 2025: First impression - Modest Q4 sales, targeting Medicare submission by mid-2026
Equity Research
Immunovia
27 Nov 2025
Equity research Immunovia, Q3 2025: US reimbursement in focus
Equity Research
Immunovia
26 Nov 2025
Equity research Immunovia: First impression, Q3 2025 - Successful rights issue to fuel launch and reimbursement progress
Equity Research
Immunovia
26 Sep 2025
Equity research Immunovia: PancreaSure launch in the US is underway
Equity Research
Immunovia
28 Aug 2025
Equity research Immunovia: Eventful Q2 and rights issue to support PancreaSure launch
Equity Research
Immunovia
02 Jul 2025
Equity research Immunovia: PancreaSure test achieves CPT code assignment
Equity Research
Immunovia
04 Jun 2025
Equity research Immunovia: New study and FDA choose not to appeal LDT ruling
Equity Research
Immunovia
15 May 2025
Equity research Immunovia: All eyes on securing the launch of PancreaSure
Equity Research
Immunovia
01 Apr 2025
Equity Research Immunovia: Regulatory tailwind in the USA following ruling against the FDA
Equity Research
Immunovia
19 Mar 2025
Equity Research Immunovia: Second clinical validation of next-generation test
Equity Research
Immunovia
26 Feb 2025
Equity Research Immunovia: Making headway with new cancer screening test
Equity Research
Immunovia
11 Dec 2024
Investment Case Immunovia: Promising clinical data and incoming triggers
Equity Research
Immunovia
